isotretinoin
isotretinoin is a pharmaceutical drug with 97 clinical trials. Currently 10 active trials ongoing. Historical success rate of 91.2%.
Success Metrics
Based on 62 completed trials
Phase Distribution
Phase Distribution
31
Early Stage
25
Mid Stage
29
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.8%
62 of 74 finished
16.2%
12 ended early
10
trials recruiting
97
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Isotretinoin on Smell
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm
Therapy for Children With Advanced Stage Neuroblastoma
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Clinical Trials (97)
Effects of Isotretinoin on Smell
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm
Therapy for Children With Advanced Stage Neuroblastoma
Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma
Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
Weekly Isotretinoin vs Tetracycline for Moderate Acne
Assessment of Serum Catestatin Level in Acne Vulgaris Patients
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET
Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema
Effects of Isotretinoin on CYP2D6 Activity
Effect of Systemic Isotretinoin on Serum Irisin Level in Acne Vulgaris Patients
13-cis Retinoic Acid (Isotretinoin) and Sperm Production
Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 97